BiotechTube
Home/ImmuPharma/Ketan Patel
KP

Ketan Patel

Independent Non-Executive Director

ImmuPharma

Therapeutic Areas

Autoimmune DiseasesType 1 Diabetes

ImmuPharma Pipeline

DrugIndicationPhase
P140 (Lupuzor)Systemic Lupus Erythematosus (SLE) / Autoimmune DiseasesPhase 2
KapiglucagonType 1 Diabetes (for use in artificial pancreas)Pre-clinical

Leadership Team at ImmuPharma

LB
Lisa Baderoon
Non-Executive Director & Head of Investor Relations
DL
Dr. Laurence Reilly
Senior Independent Non-Executive Director, Chair of Audit Committee
View full ImmuPharma profile